Status:
COMPLETED
Lung CT Scan Analysis of SARS-CoV2 Induced Lung Injury
Lead Sponsor:
University of Milano Bicocca
Conditions:
covid19
Eligibility:
All Genders
18+ years
Brief Summary
This is a multicenter observational retrospective cohort study that aims to study the morphological characteristics of the lung parenchyma of SARS-CoV2 positive patients identifiable in patterns throu...
Detailed Description
BACKGROUND: In February, the first case of SARS-CoV2 positive patient was recorded in Lombardy (Italy), a virus capable of causing a severe form of acute respiratory failure called Coronavirus Diseas...
Eligibility Criteria
Inclusion
- Inclusion Criteria (COVID-19 cohort):
- Patients 18 years old or above;
- Positive confirmation with nucleic acid amplification test or serology of SARS-CoV2 by naso-pharyngeal swab, bronchoaspirate sample or bronchoalveolar lavage;
- Lung CT scan performed within 7 days of hospital admission;
- Inclusion criteria (ARDS cohort):
- Patients above 18 years old or above;
- Patients admitted to the hospital with a diagnosis of ARDS according to the Berlin criteria;
- Lung CT scan performed within 7 days of ARDS diagnosis;
- Exclusion criteria (ARDS cohort):
- ● Positive confirmation with nucleic acid amplification test or serology of SARS-CoV2 by naso-pharyngeal swab, bronchoaspirate sample or bronchoalveolar lavage
Exclusion
Key Trial Info
Start Date :
May 7 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2022
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT04395482
Start Date
May 7 2020
End Date
March 31 2022
Last Update
July 21 2022
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Ospedale Papa Giovanni XXIII
Bergamo, Italy
2
Policlinico San Marco-San Donato group
Bergamo, Italy
3
Azienda Ospedaliero-Universitaria di Ferrara
Ferrara, Italy
4
ASST di Lecco Ospedale Alessandro Manzoni
Lecco, Italy